[1]何志钧,梁运啸,梁列新.质子泵抑制剂治疗上消化道出血对痛风复发的影响[J].医学信息,2019,32(01):154-156.[doi:10.3969/j.issn.1006-1959.2019.01.048]
　HE Zhi-jun,LIANG Yun-xiao,LIANG Lie-xin.Effect of Proton Pump Inhibitor on Upper Gastrointestinal Hemorrhage on Recurrence of Gout[J].Journal of Medical Information,2019,32(01):154-156.[doi:10.3969/j.issn.1006-1959.2019.01.048]
点击复制

质子泵抑制剂治疗上消化道出血对痛风复发的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年01期
页码:
154-156
栏目:
药物与临床
出版日期:
2019-01-01

文章信息/Info

Title:
Effect of Proton Pump Inhibitor on Upper Gastrointestinal Hemorrhage on Recurrence of Gout
文章编号:
1006-1959（2019）01-0154-03
作者:
何志钧; 梁运啸; 梁列新
广西壮族自治区人民医院消化内科，广西 南宁 530000
Author(s):
HE Zhi-jun; LIANG Yun-xiao; LIANG Lie-xin
Department of Gastroenterology,People's Hospital of Guangxi Zhuang Autonomous Region,Nanning 530000,Guangxi,China
关键词:
质子泵抑制剂; 上消化道出血; 痛风; 发热
Keywords:
Intervertebral foramen; Recurrence; Risk factors; Lumbar spinal stenosis
分类号:
R573.2；R589.7
DOI:
10.3969/j.issn.1006-1959.2019.01.048
文献标志码:
A
摘要:
目的 通过观察上消化道出血的痛风患者使用质子泵抑制剂（PPI）治疗前后临床症状及尿酸的变化，以探讨PPI治疗上消化道出血对痛风复发的影响。方法 选择我院上消化道出血合并原发性痛风患者37例为痛风组，同期37例上消化道出血且无痛风患者为对照组。两组患者在使用PPI前后分别监测尿酸、体温、关节肿痛等指标，并对相关指标进行统计学分析。结果 痛风组使用PPI后血尿酸较用药前升高（49.24±111.49）μmol/L，差异有统计学意义（P＜0.05）；对照组PPI使用后血尿酸较用药前升高（2.89±47.87）μmol/L，但差异无统计学意义（P＞0.05）。痛风组用药前后尿酸变化差值大于对照组，差异有统计学意义（P＜0.05）。使用PPI治疗后，痛风组64.86%出现非感染性发热，75.68%出现新发关节疼痛，患者疼痛评分较用药前增加（P＜0.001），而对照组患者未出现关节痛及发热病例。结论 上消化道出血的痛风患者使用PPI可能诱发或加重痛风疾病的活动。
Abstract:
Objective To investigate the effects of PPI on upper gastrointestinal bleeding and gout recurrence by observing the changes of clinical symptoms and uric acid before and after treatment with proton pump inhibitor (PPI) in gout patients with upper gastrointestinal bleeding. Methods 37 patients with upper gastrointestinal hemorrhage complicated with primary gout were selected as gout group. 37 patients with upper gastrointestinal hemorrhage and no gout were the control group. The two groups of patients were monitored for uric acid, body temperature, joint swelling and pain before and after the use of PPI, and the relevant indicators were statistically analyzed. Results After the use of PPI in the gout group, the blood uric acid increased (49.24±111.49) μmol/L, the difference was statistically significant (P<0.05). The blood uric acid increased after the use of PPI in the control group (2.89±47.87)μmol/L, but the difference was not statistically significant (P>0.05). The difference of uric acid changes before and after treatment in the gout group was greater than that in the control group,the difference was statistically significant (P<0.05). After treatment with PPI, 64.86% of the gout group had non-infectious fever, 75.68% had new-onset joint pain, and the patient's pain score increased before the medication (P<0.001), while the control group did not have joint pain and fever. Conclusion The use of PPI in gout patients with upper gastrointestinal bleeding may induce or aggravate gout disease activity.

参考文献/References:

[1]曾小峰,陈耀龙.2016中国痛风诊疗指南[J].浙江医学,2017,39(21):1823-1832.
[2]Neogi T,Jansen TL,Dalbeth N,et al.2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative[J].Ann Rheum Dis,2015,74(10):1789-1798.
[3]Kraut JA,Starr F,Sachs G,et al.Expression of gastric and colonic H+-K+-ATP ase in the rat kidney[J].Am J Physiol,1995,268(4 Pt 2):F581-F587.
[4]陈钟鸣,高晓燕,王延庆,等.质子泵抑制剂诱发有痛风病史的上消化道出血患者急性痛风性关节炎发作的临床观察及治疗[J].医学信息,2014,27(39):365-366.
[5]王淑玲,姜葵,陈鑫,等.质子泵抑制剂诱发痛风性关节炎急性发作病例回顾并可能机制分析[J].世界华人消化杂志,2017(9):852-856.
[6]Kamal F,Khan MA,Molnar MZ,et al.The Association Between Proton Pump Inhibitor Use With Acute Kidney Injury and Chronic Kidney Disease[J].Journal of Clinical Gastroenterology,2018,52(6):468-476.
[7]周荣斌,林霖.《急性上消化道出血急诊诊治流程专家共识（修订稿）》的阐释[J].中国全科医学,2015(33):4021-4024.
[8]徐城,杨晓秋,刘丹彦.常用的疼痛评估方法在临床疼痛评估中的作用[J].中国疼痛医学杂志,2015,21(3):210-212.
[9]Gumz ML,Lynch IJ,Greenlee MM,et al.The renal H+-K+-ATP ases: physiology, regulation, and structure[J].Am J Physiol Renal Physiol,2010,298(1):F12-F21.
[10]Yang Y,George KC,Shang WF,et al.Proton-pump inhibitors use, and risk of acute kidney injury: a meta-analysis of observational studies[J].Drug Design Development & Therapy,2017(11):1291-1299.

相似文献/References:

[1]冯曲波,颜 婷,伍国林.2014年~2016年我院质子泵抑制剂应用分析[J].医学信息,2018,31(08):116.[doi:10.3969/j.issn.1006-1959.2018.08.039]
　FENG Qu-bo,YAN Ting,WU Guo-lin.Application of Proton Pump Inhibitors in our Hospital from 2014 to 2016[J].Journal of Medical Information,2018,31(01):116.[doi:10.3969/j.issn.1006-1959.2018.08.039]
[2]高 颖.消化内镜下局部药物联合去甲肾上腺素治疗 上消化道出血的疗效观察[J].医学信息,2018,31(10):104.[doi:10.3969/j.issn.1006-1959.2018.10.032]
　GAO Ying.Clinical Observation of Digestive Endoscopy Combined with Norepinephrine in the Treatment of Upper Gastrointestinal Bleeding[J].Journal of Medical Information,2018,31(01):104.[doi:10.3969/j.issn.1006-1959.2018.10.032]
[3]毕月玲,潘丽华,闫永悦.2017年第一、二季度我院口服质子泵抑制剂 应用情况分析[J].医学信息,2018,31(10):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
　BI Yue-ling,PAN Li-hua,YAN Yong-yue.Application of Oral Proton Pump Inhibitors in our Hospital in the First,Second Quarter of 2017[J].Journal of Medical Information,2018,31(01):119.[doi:10.3969/j.issn.1006-1959.2018.10.038]
[4]陈艳玲.内镜下止血术联合奥曲肽治疗上消化道出血的临床效果[J].医学信息,2022,35(11):141.[doi:10.3969/j.issn.1006-1959.2022.11.037]
　CHEN Yan-ling.Clinical Effect of Endoscopic Hemostasis Combined with Octreotide in the Treatment of Upper Gastrointestinal Bleeding[J].Journal of Medical Information,2022,35(01):141.[doi:10.3969/j.issn.1006-1959.2022.11.037]
[5]张宏程.生长抑素联合泮托拉唑治疗肝硬化合并上消化道出血的疗效观察[J].医学信息,2019,32(03):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
　ZHANG Hong-cheng.Therapeutic Effect of Somatostatin Combined with Pantoprazole on Hepatic Cirrhosis Complicated with Upper Gastrointestinal Hemorrhage[J].Journal of Medical Information,2019,32(01):153.[doi:10.3969/j.issn.1006-1959.2019.03.050]
[6]高华初.泮托拉唑治疗消化性溃疡合并上消化道出血的临床价值评价[J].医学信息,2018,31(22):153.[doi:10.3969/j.issn.1006-1959.2018.22.045]
　GAO Hua-chu.Clinical Value of Pantoprazole in the Treatment of Peptic Ulcer Complicated with Upper Gastrointestinal Bleeding[J].Journal of Medical Information,2018,31(01):153.[doi:10.3969/j.issn.1006-1959.2018.22.045]
[7]张许林,余泽波.肝硬化上消化道出血的输血治疗进展[J].医学信息,2019,32(08):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
　ZHANG Xu-lin,YU Ze-bo.Progress in Transfusion Therapy for Upper Gastrointestinal Hemorrhage[J].Journal of Medical Information,2019,32(01):85.[doi:10.3969/j.issn.1006-1959.2019.08.025]
[8]周佳美,张晓娟,王明蕾,等.上消化道出血住院患者临床特征分析[J].医学信息,2019,32(16):116.[doi:10.3969/j.issn.1006-1959.2019.16.037]
　ZHOU Jia-mei,ZHANG Xiao-juan,WANG Ming-lei,et al.Analysis of Clinical Features of Hospitalized Patients with Upper Gastrointestinal Bleeding[J].Journal of Medical Information,2019,32(01):116.[doi:10.3969/j.issn.1006-1959.2019.16.037]
[9]吴忠军,林 涛,胡 彬.兰索拉唑、奥曲肽、凝血酶三联治疗重症上消化道出血的临床疗效及并发症观察[J].医学信息,2021,34(24):64.[doi:10.3969/j.issn.1006-1959.2021.24.013]
　WU Zhong-jun,LIN Tao,HU Bin.Clinical Effects and Complications of Lansoprazole, Octreotide and Thrombin in the Treatment of Severe Upper Gastrointestinal Hemorrhage[J].Journal of Medical Information,2021,34(01):64.[doi:10.3969/j.issn.1006-1959.2021.24.013]
[10]李光明,曾军红,郭香莲.奥曲肽联合泮托拉唑治疗老年消化性溃疡合并上消化道出血的疗效及对凝血功能和炎症因子的影响[J].医学信息,2022,35(22):99.[doi:10.3969/j.issn.1006-1959.2022.22.020]
　LI Guang-ming,ZENG Jun-hong,GUO Xiang-lian.Efficacy of Octreotide Combined with Pantoprazole in the Treatment of Elderly Peptic Ulcer Complicated with Upper Gastrointestinal Hemorrhage and its Effect on Coagulation Function and Inflammatory Factors[J].Journal of Medical Information,2022,35(01):99.[doi:10.3969/j.issn.1006-1959.2022.22.020]

更新日期/Last Update: 2019-01-22